Esperite N.V.: Samples and Database are safe. The recent articles published about CryoSave on loss of samples are poorly info...
10 Février 2020 - 7:17AM
Esperite N.V.: Samples and Database are safe. The recent articles
published about CryoSave on loss of samples are poorly informed and
defamatory.
Samples and Database are safe
Amsterdam, The Netherlands – 10
February 2020
Esperite N.V. (Euronext: ESP, “Esperite”)
has noticed several articles in the news, online channels and
information blogs about a hypothetical loss of umbilical cord blood
samples during the transport from Belgium, Switzerland to Poland.
Esperite has published since September 26th 2019 a CryoSave section
on its website which describes the different steps from the
transaction with the Polish partner, Myrisoph and CryoSave to the
current status after the transportation of the samples. Esperite
confirms that the inventory system, a sophisticated database was up
to date and totally functional when transferred. All the samples in
inventory were reported and identified.Esperite was surprised that
none of the two companies, PBKM Famicord and Myrisoph CSG-Bio
contacted Esperite in order to discuss this matter. Esperite could
have helped PBKM Famicord and Myrisoph CSG-Bio to understand better
the structure of the database, its logical and secured
organisation, the required procedures and the traceability in place
for the samples.Esperite could have helped them to avoid such a
chaos in their communication. The journalists didn’t contact
Esperite to verify their information. Esperite feels sorry for the
parents which have been worried by this current situation and
confirm offering to PBKM Famicord and Myrisoph CSG-Bio all the
needed support in case Esperite is invited to do so.Esperite
believes that PBKM Famicord and Myrisoph CSG-Bio, are now in a
beauty contest, using this fortunate confusion to obtain from the
clients new agreements on additional storage contracts.
To contact Esperite: info@esperitegroup.com.
ESPERITE N.V is listed at Euronext Amsterdam and
Euronext Paris,
- Samples in the news - 10 February 2020 Press Release